title: Sirolimus in combination with tacrolimus in allogeneic stem cell transplantation--timing and conditioning regimen may be crucial.
authors.forename: Daniel
authors.initials: D
authors.lastname: Wolff
authors.forename: Holger
authors.initials: H
authors.lastname: Andree
authors.forename: Inken
authors.initials: I
authors.lastname: Hilgendorf
authors.forename: Jochen
authors.initials: J
authors.lastname: Casper
authors.forename: Mathias
authors.initials: M
authors.lastname: Freund
authors.forename: Christian
authors.initials: C
authors.lastname: Junghanss
mesh_terms: D000368:Aged; D002985:Clinical Protocols; D004359:Drug Therapy, Combination; D006086:Graft vs Host Disease / Q000517:prevention & control*; D018380:Hematopoietic Stem Cell Transplantation / Q000009:adverse effects / Q000379:methods; D006801:Humans; D008875:Middle Aged; D012189:Retrospective Studies; D020123:Sirolimus / Q000627:therapeutic use*; D016559:Tacrolimus / Q000627:therapeutic use*; D013997:Time Factors
chemical_list: D020123:Sirolimus; D016559:Tacrolimus